oru.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
S100B Is an Important Outcome Predictor in Traumatic Brain Injury
Department of Clinical Neuroscience, Section for Neurosurgery, Karolinska University Hospital Solna, Stockholm, Sweden.
Department of Economics, Stockholm University, Stockholm, Sweden.ORCID iD: 0000-0002-1445-7699
Department of Physiology and Pharmacology, Section of Anesthesiology and Intensive Care, Karolinska University Hospital Solna, Stockholm, Sweden.
Department of Clinical Neuroscience, Section for Neurosurgery, Karolinska University Hospital Solna, Stockholm, Sweden.
2013 (English)In: Journal of Neurotrauma, ISSN 0897-7151, E-ISSN 1557-9042, Vol. 30, no 7, p. 519-528Article in journal (Refereed) Published
Abstract [en]

The objective of the study was to examine how S100B, a biomarker of traumatic brain injury (TBI), contributes to outcome prediction after adjusting for known parameters, including age, Glasgow Coma Scale (GCS), pupil reaction, and computed tomography (CT) variables; to examine which parameters have the best correlation to elevated serum levels of S100B; and to investigate when to sample S100B to achieve the strongest association to outcome. This retrospective study included 265 patients with TBI admitted to the neurointensive care unit, Karolinska University Hospital Solna, Stockholm, Sweden. Univariate and multivariate proportional odds regressions were performed to determine parameters most closely related to outcome, and how S100B adds to prediction accuracy. Age (p < 0.0001), pupil reaction (p < 0.0001), and levels of S100B (p < 0.0001) had the strongest statistical correlation to outcome. The area under curve of S100B, the first 48 h after trauma, yielded an additional explained variance of 6.6% in excess of known outcome parameters, including age, GCS, pupil reaction, and CT variables, themselves exhibiting an explained variance of 29.3%. S100B adds substantial information regarding patient outcome, in excess of that provided by known parameters. Only CT variables were found to be significant predictors of increased levels of S100B in uni- and multivariate analysis. Early samples of S100B, within 12 h after trauma, appear to have little prognostic value, and S100B should likely be sampled 12-36 h following trauma to best enhance TBI outcome prediction.

Place, publisher, year, edition, pages
Mary Ann Liebert, 2013. Vol. 30, no 7, p. 519-528
Keywords [en]
Biomarkers, humans, outcome, S100B, TBI
National Category
Neurosciences Neurology
Identifiers
URN: urn:nbn:se:oru:diva-66422DOI: 10.1089/neu.2012.2553ISI: 000318150300003PubMedID: 23297751Scopus ID: 2-s2.0-84876939368OAI: oai:DiVA.org:oru-66422DiVA, id: diva2:1196360
Funder
Stockholm County CouncilThe Karolinska Institutet's Research Foundation
Note

AuthorCount:4;

Available from: 2018-04-09 Created: 2018-04-09 Last updated: 2018-04-10Bibliographically approved

Open Access in DiVA

No full text in DiVA

Other links

Publisher's full textPubMedScopus

Authority records BETA

Johannesson, Louise

Search in DiVA

By author/editor
Johannesson, Louise
In the same journal
Journal of Neurotrauma
NeurosciencesNeurology

Search outside of DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 14 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf